Alzheimer's disease, a progressive neurodegenerative condition, is distinguished by the misfolding and aggregation of proteins within the brain. Beta-amyloid plaques and tau tangles are the main offenders, disrupting neuronal communication and triggering symptoms such as memory loss, cognitive decline, and behavioral changes. This accumulation of abnormal proteins progressively impairs brain function, marking Alzheimer's as the most prevalent form of dementia globally. The disease presents formidable challenges for healthcare systems and families alike. Ongoing research is focused on unraveling the mechanisms behind protein misfolding, identifying early biomarkers, and developing novel therapies to either slow down or stop its advancement. Effective treatments remain elusive, underscoring the intricate nature of protein misfolding diseases and emphasizing the critical need for innovative approaches in diagnosis and treatment.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China